anthonyyazdaniml/gliner-biomed-curated-corpus huggingface dataset:
Increasingly, emergency department patients for whom a non-ischemic etiology of acute coronary syndrome (ACS) symptoms cannot be identified undergo further evaluation to rule out myocardial ischemia and appraisal of cardiovascular risk factors (CRFs) in chest pain observation units (CPOUs). CPOU admission may represent a "teachable moment," but there has been little research on the effectiveness of brief, practical interventions for cardiovascular risk reduction in this population, despite the fact that the vast majority of these patients have at least one modifiable CRF and many do not receive regular primary care follow-up. The purpose of this study is to determine whether a brief counseling intervention initiated in the CPOU has a significant impact upon health attitudes (readiness to change) and cardiovascular risk-related behaviors (diet, exercise, and smoking). Based on the Health Belief Model (HBM), the intervention is designed to provide patients with tailored information on their cardiovascular risk, to negotiate goals for change, and to build problem-solving skills. All participants who are admitted to the CPOU for evaluation of ACS symptoms will be randomized to brief intervention (face-to-face counseling in the CPOU, coupled with telephone counseling at 4 weeks) or to minimal intervention (booklet with general information on CRFs) after a negative initial troponin measurement. We will conduct a baseline survey and follow-up telephone interviews at 2- and 6-month to assess stage of change and CRF-related behaviors. Linear mixed models and logistic regression (with generalized estimating equations) will be used to compare continuous and dichotomous behavioral outcomes across treatment arms, respectively. The proposed trial will evaluate the feasibility and effectiveness of delivering brief interventions for cardiovascular risk reduction in the CPOU setting, will provide insight into mechanisms of behavior change in these patients, and will guide the development of future case management interventions.
Objectives: The first purpose of this study was to determine time to attainment of symptomatic remissions and recoveries of 2-12 years duration for those with borderline personality disorder (BPD) and patients with other personality disorders (OPDs); the second was to determine the stability of these outcomes. Methods: Two hundred ninety inpatients meeting both Revised Diagnostic Interview for Borderlines (DIB-R) and DSM III-R criteria for BPD and 72 patients with OPDs were assessed during their index admission using a series of semistructured interviews. The same instruments were readministered at 12 contiguous 2-year time periods. Results: Patients with BPD were significantly slower to achieve remission or recovery (which involved good social and vocational functioning as well as symptomatic remission) than patients with OPD. However, those in both study groups ultimately achieved about the same high rates of remission (BPD patients: 77%-100%; patients with OPD: 97%-100%) but not recovery (37%-60% vs 68%-89%) by the time of the 24-year follow-up. In contrast, symptomatic recurrence (11%-40% vs 5%-10%) and loss of recovery (29%-59% vs 15%-42%) occurred more rapidly and at substantially higher rates among BPD patients than patients with OPD. Conclusions: Taken together, the results of this study suggest that sustained symptomatic remission is substantially more common than sustained recovery from BPD. They also suggest that loss of sustained recovery is more common than symptomatic recurrences for those with BPD.
In this study, the CLDN18.2/PD-L1 dual-targeting CAR-T cells will be injected intravenously to patients with CLDN18.2-positive advanced solid tumors, such as gastric adenocarcinoma or gastroesophageal junction adenocarcinoma and pancreatic adenocarcinoma, who had nearly no response to standard treatment. The safety and effectiveness will be evaluated. The safety evaluation standard refers to the standard of CTCAE 5.0. The evaluation standard of effectiveness refers to the evaluation standard of solid tumor curative effect RECIST 1.1 to evaluate the curative effect.

There are two phases of this study. The first is dose escalation phase, and 9 patients with CLDN18.2-positive advanced solid tumors are planned to be enrolled. The second is dose expansion phase. The curative effect has been observed in the first phase, and after the DLT observation period of the related dose group finished, the PI will decide whether to conduct the dose expansion research finally. It is planned to enroll 20 patients in dose expansion phase.
Patients diagnosed with poor ovarian response will be included in the study. The definition of poor response was based on the presence of at least one of the following criteria: Age \> 40 years old, day 2 FSH \>9.5 mIU/ml, AMH \< 2ng/ml ,at least one previous COH with less than 3 oocytes retrieved, at least one cancelled attempt due to poor response, estradiol less than 500 pg/ml on the day of HCG. All patients will be counseled regarding their prognosis and other treatment options including oocyte donation as well as adoption were also presented and discussed in detail. Early follicular phase FSH, estradiol (E2) and Anti-Mullerian Hormone (AMH) will be measured prior to the initiation of treatment. Women in the Clomiphene group will receive 100-150 mg of Clomiphene citrate once per day for 5 days in combination with gonadotropins according to short GnRH-antagonist protocol: all women will have measurements of serum FSH and estradiol and a pelvic sonogram on the second day of their cycle. Providing that serum FSH is \< 17 mIU/ml and estradiol is \< 70 pg/ml on day 2 , ovarian stimulation will be initiated with 100-150 mg of Clomiphene citrate in combination with 450 IU of gonadotropins either in the form of a combination of highly purified urinary FSH and LH or with a combination of Rec FSH and Rec LH. All patients will be re-evaluated on day 5 of the stimulation, and dosage adjustments will be made and the antagonists (Cetrorelix or ganirelix 0.25 mg/day) will be initiated. When at least 2 follicles reach an average diameter of 17 mm, final oocyte maturation will be triggered with 10,000IU of hCG ( Pregnyl, Organon, Greece Inc.). Oocyte retrieval will be performed 34 to 36 hours later. All patients will undergo ICSI. Patients with successful fertilization will have embryo transfer under sonographic guidance on day 3 after retrieval. Women in the Gonadotropin group will receive only gonadotropins according to short GnRH-antagonist protocol as it was mentioned above.
Participants will perform the HIIT protocol on an electronically-braked cycle ergometer (Quinton Excalibur, Quinton Instrument Company, Bothell, WA). Participants will perform a 20-minute protocol, consisting of four minutes of cycling at 15% of maximum anaerobic power (Max-AP) followed by 30 seconds at 85% of Max-AP. These workloads will be based upon pre-trial Wingate tests. This cycle was repeated four times within each protocol, ending with two minutes at 15% of Max-AP. This will be performed 3d/wk for 6wks, with at least 24 hrs between each session.
Housing insecurity is associated with co-occurring depression and pain interfering with daily activities. Network analysis of depressive symptoms along with associated risk or protective exposures may identify potential targets for intervention in patients with co-occurring bodily pain. In a community-based sample of adults (n = 408) living in precarious housing or homelessness in Vancouver, Canada, depressive symptoms were measured by the Beck Depression Inventory; bodily pain and impact were assessed with the 36-item Short Form Health Survey. Network and bootstrap permutation analyses were used to compare depressive symptoms endorsed by Low versus Moderate-to-Severe (Mod + Pain) groups. Multilayer networks estimated the effects of risk and protective factors. The overall sample was comprised of 78% men, mean age 40.7 years, with 53% opioid use disorder and 14% major depressive disorder. The Mod + Pain group was characterized by multiple types of pain, more persistent pain, more severe depressive symptoms and a higher rate of suicidal ideation. Global network connectivity did not differ between the two pain groups. Suicidal ideation was a network hub only in the Mod + Pain group, with high centrality and a direct association with exposure to lifetime trauma. Antidepressant medications had limited impact on suicidal ideation. Guilt and increased feelings of failure represented symptoms from two other communities of network nodes, and completed the shortest pathway from trauma exposure through suicidal ideation, to the non-prescribed opioid exposure node. Interventions targeting these risk factors and symptoms could affect the progression of depression among precariously housed patients.
A comparison was conducted between robot-assisted radical prostatectomy (RARP) performed using the Hugo RAS System and the Da Vinci System. We conducted an extensive search of online databases through September 2024. The data from eligible studies were pooled and analyzed with Review Manager 5.4, employing a random effects model. Weighted mean difference (WMD) and odds ratios (OR) with 95% confidence intervals (CI) were used to analyze continuous and categorical variables. A total of eight original studies, involving 1155 patients (HUGO-RARP: 468 vs. da Vinci-RARP: 687), were included. Compared with da Vinci-RARP, HUGO-RARP had a longer docking time (WMD: 6.2 min; 95% CI 4.25-8.14; p < 0.0001), while no significant differences were observed in total operative time, console time, bladder neck dissection time, seminal vesicle dissection time, vesicourethral anastomosis time, or pelvic lymph node dissection time between two systems. There were no significant differences in hospital stay, estimated blood loss, catheter duration, or complication rates. Likewise, oncological and functional outcomes were similar between the two systems. While these results suggest that the Hugo RAS system performs as well as the Da Vinci system in RARP, more randomized controlled studies are needed to further evaluate prognostic outcomes.
The invention discloses application of juglans mandshurica maxim. peel or bark ethyl acetate part in preparing a blood sugar reducing medicament, in particular new application of the juglans mandshurica maxim. peel or bark ethyl acetate part in preparing an alpha-glucosidase inhibitor medicament. The alpha-glucosidase inhibitor medicament can be prepared from the juglans mandshurica maxim. ethyl acetate part or a composition containing the juglans mandshurica maxim. ethyl acetate part.
PROBLEM TO BE SOLVED: To provide a method for producing a plaster material by which the productivity can be improved. SOLUTION: A peripheral end of an air-permeability regulating sheet 2 is thermally melted and sealed with a film application supporting unit 5 in a press 21 to form each bag unit (2 and 5). An exothermic agent 8 is then filled in the bag unit (2 and 5) to seal an opening of the bag unit (2 and 5). Thereby, each exothermic unit 9 is formed. A covering sheet 11 is fed toward a running area of the exothermic unit 9 in a line. A plaster 12 fed from a tank 22 during the feed of the covering sheet 11 is applied through a pipe 23 and a nozzle 23α to either of surfaces of the covering sheet 11.
PURPOSE:To provide the title medium capable of easy preparation at a low cost, free from concern for health hazard, useful for diagnosing diseases such as tumors, angiopathy, inflammation, teratosis, deformation, cacochymia, etc. CONSTITUTION:Manganese(III)-contg. acidic phosphatase as active ingredient is dissolved in water, physiological saline or ethanol in the presence of e.g. a buffer solution with its use physiologically permitted such as of sodium dihydrogenphosphate followed by sterilization, thus giving the objective contrast medium. Said enzyme, a hydrolase, which is found in sweet potatoes, rice, wheat, corn, potatoes soybeans, spinach leaves etc., can be isolated by established means. For administration, either peroral or intravascular route is possible; the concentration in the administration is 0.1-20wt.% per unit/mg (on an enzyme solid basis) of activity in the case of peroral administration, while for intravascular administration, 1-40 (pref. esp. 5-20)wt.%.
A system for tracking biomarkers in subjects. In one embodiment, the biomarker tracking system has a sensory array including an RGB-D camera or RGB camera, a memory, and an electronic processor. The microphone captures voice data, including but not limited to tremor detection data, speech volume and pronunciation data, speech strength data, changes in tonality, hesitance in voice, and changes in speed or verbiage. A stored baseline biomarker model may comprise a voice data profile which may be pre-stored in the memory of a server and include a plurality of benchmarks. This electronic processor is configured to use this pre-stored voice data and compare it to the voice data captured with the microphone. The electronic processor is further configured to determine a set of attributes for the voice data, and generates a speech data deviation model based, at least in part, on the comparison of the speech data to the stored baseline biomarker model.
Cognitive flexibility is critical for humans to perform complex tasks and ensures that humans exhibit appropriate behaviour in response to changing environments. Successful implementation of cognitive flexibility involves several sub-domains within executive functions. Prior researches on cognitive flexibility has portrayed it as various aspects of human cognition ranging from a cognitive skill related to set-shifting, or a by-product of cognitive processes, to part of the cognitive system. The operationalization of cognitive flexibility has been particularly difficult due to its multi-faceted nature. Current flexibility interventions and neuroimaging studies examining cognitive flexibility commonly utilise tasks that taps on to executive functions such as task-set switching or the Dimensional Change Card Sort (DCCS) task. Although effective, one concern related to using these tasks is that it does not tap merely into cognitive flexibility but also activate other executive functions such as inhibition and working memory. Hence, this reduces the precision and specificity of these tasks as training tools. The present project proposed structure learning as a more fundamental and apt training approach. It involves seeking patterns in the stochastic presentations of stimuli, without the need for explicit feedback and is in itself a basic building block for cognitive flexibility.

In the educational context, structure learning is analogous to patterning, a crucial cognitive ability that underpins mathematical and reading skills. Prior research has demonstrated a close relationship between pattern understanding and cognitive flexibility. Hence, structure learning training could potentially be beneficial in improving one's cognitive flexibility. Furthermore, emerging evidence has demonstrated that domain-general training of structure learning skills produced learning that transfer well beyond the learning task. However, there is a paucity in studies that examined whether structure learning training per se could produce generalisable improvements in cognitive flexibility. The present study aims to address this gap by examining if structure learning training, relative to working memory training and having no training, could produce changes in neural markers that relate to potential gains in cognitive flexibility.
A timely inflammatory response is crucial for early viral defense, but uncontrolled inflammation harms the host. Retinoic acid-inducible gene I (RIG-I) has a pivotal role in detecting RNA viruses, yet the regulatory mechanisms governing its sensitivity remain elusive. Here we identify PTENα, an N-terminally extended form of PTEN, as an RNA-binding protein with a preference for the CAUC(G/U)UCAU motif. Using both in vivo and in vitro viral infection assays, we demonstrated that PTENα restricted the host innate immune response, relying on its RNA-binding capacity and phosphatase activity. Mechanistically, PTENα directly bound to viral RNA and enzymatically converted its 5'-triphosphate to 5'-monophosphate, thereby reducing RIG-I sensitivity. Physiologically, brain-intrinsic PTENα exerted protective effects against viral inflammation, while peripheral PTENα restricted host antiviral immunity and, to some extent, promoted viral replication. Collectively, our findings underscore the significance of PTENα in modulating viral RNA- and RIG-I-mediated immune recognition, offering potential therapeutic implications for infectious diseases.
Participants 2 years of age and older with recurrent or refractory sarcoma receive R1507 as 9 mg/kg via IV infusion once weekly until disease progression, intercurrent illness, unacceptable toxicity, prolonged (2-week) time off treatment, withdrawal, loss to follow-up, investigator decision, or death. Cohort 1 includes individuals with Ewing's sarcoma who have relapsed within 24 weeks after diagnosis and have received two or more prior chemotherapy regimens.
OBJECTIVES: To examine the orientation, magnitude, and pace of secular trends in body height, weight, and body mass index (BMI) among Chinese urban students aged 7-18 years from 2000 to 2019.
METHODS: Data were extracted from Chinese urban students aged 7-18 years from the Chinese National Surveillance on Students' Constitution and Health in 2000, 2005, 2010, 2014, and 2019. The height, weight, and BMI of 548 419, 548 408, and 548 365 urban students aged 7-18 years, respectively, were tested. The mean differences across survey years were tested by one-way analysis of variance (ANOVA). The pace of secular trends is expressed as the change every 5 years between every two adjacent survey years.
RESULTS: Height increments between 1.9 and 6.2 cm, weight increments between 2.7 and 8.6 kg, and BMI increments between 0.9 and 1.9 kg/m2 were observed in boys. For girls, height increments between 1.5 and 4.9 cm, weight increments between 2.2 and 6.0 kg, and BMI increments between 0.7 and 1.7 kg/m2 were observed. The pace of secular trends in height decreased in the last 5 years, and the secular trends in weight and BMI have accelerated in the last 9 years compared with the previous 10 years.
CONCLUSIONS: Although the secular trend in height among Chinese urban students has slowed, it has not yet reached its genetic potential and continues to increase. The rapid increase in weight and BMI was a cause for concern. Our findings provide a basis for the future formulation of public health interventions in China.
Candida bloodstream infections in children are of special concern in neonatal and pediatric intensive care and patients with comorbidities. This study aimed to estimate the incidence and risk factors associated with mortality in candidemia cases occurring in a public children's hospital in Ribeirao Preto, Brazil. It is a retrospective transversal study. Every patient under the age of 18 admitted to the study facility from January 1, 2013, to December 31, 2019, was considered potentially eligible to be included if they had candidemia. We collected clinical data from medical records. We included 113 blood cultures yielding positive results for Candida. The incidence rate was 2.12 per 1000 admissions. The most common Candida species was Candida parapsilosis. Septic shock during the candidemia episode was the only clinical outcome associated with a relative risk-adjusted (RRa) of 2.77 with an interval >1 (1.12-6.85). Our findings show that the incidence rate and mortality rates of candidemia are in line with those in other children's services in Brazil. We found a global mortality rate of 28.31% (32/113) from candidemia episodes. We highlight the predominance of non-albicans Candida species including C. parapsilosis. Septic shock was the most important factor showing a significant risk of mortality.
Patients receive Akt inhibitor MK-2206 PO on days 1, 8, 15, and 22 (days 8, 15, and 22 of course 1) and selumetinib PO on days 1, 8, 15, and 22. Courses repeat every 28 days in the absence of disease progression or unacceptable toxicity.
###  Risk Summary 

The use of Skyla is contraindicated in pregnancy or with a suspected pregnancy and Skyla may cause adverse pregnancy outcomes [see Contraindications (4), Warnings and Precautions (5.1, 5.2)]. If a woman becomes pregnant with Skyla in place, the likelihood of ectopic pregnancy is increased and there is an increased risk of miscarriage, sepsis, premature labor, and premature delivery. Remove Skyla, if possible, if pregnancy occurs in a woman using Skyla. If Skyla cannot be removed, follow the pregnancy closely [see Warnings and Precautions (5.1, 5.2)].

There have been isolated cases of virilization of the external genitalia of the female fetus following local exposure to LNG during pregnancy with an LNG IUS in place. Animal reproduction studies have not been conducted with Skyla.
During 1 of the 3 six-month periods of participation, families will receive 24 weekly sessions of Early Social Interaction via Mobile Coaching (ESI-MC) by a trained early intervention provider. ESI-MC is an evidence-based parent-implemented intervention for toddlers with ASD. ESI teaches parents how to support their child's social communication, language, play and behaviors in everyday routines, activities, and places. Program planning entails building consensus with families on priority targets for the child and teaching strategies and supports for the parents using manualized conversational steps, Baby Navigator social communication milestones, and ESI content for families to practice 25 hours per week. Families will be invited to participate in the online Autism Navigator How-To Guide, a self-guided web-based course and companion online group education meetings. Families will also receive Treatment as Usual (TAU).
FIELD: cosmetics, particularly, toilet soap production. SUBSTANCE: toilet soap with nourishing cream contains sodium salt of fat acids of food fats, palm and coconut oils, sodium chloride, pigmentary titanium dioxide, antioxidant, perfume composition. The soap additionally has nourishing cream and citric acid as a neutralizing agent. The toilet soap with nourishing cream is produced by stage-by-stage saponification of fats with solution of caustic soda, lamination of soapy glue by sodium chloride, polishing, settling and pouring of base. Then product is dried and subjected to mechanical treatment, and additives and perfume composition are introduced. After it, filing with following forming, cutting and stamping are carried out. After base pouring, soapy mass is additionally neutralized by solution of citric acid and after drying, nourishing cream is introduced. EFFECT: new soap without irritating and allergic action on skin. 2 tbl
Subjects will watch 30-second videos, with a one-minute break between videos. The videos show the actions that subjects should imagine while watching the video.
The invention provides a deep venipuncture guide wire video monitoring system, a method and electronic equipment, and relates to the technical field of deep venipuncture catheter placement for medical critical care. The system comprises: and the information extraction module is used for extracting video key information of the deep venipuncture. And the flow understanding module is used for forming flow understanding information based on the first logic rule and the video key information. And the state detection module is used for formulating a second logic rule based on the video key information and the flow understanding information, judging the state of the guide wire according to the second logic rule, and giving an alarm if the tail end of the guide wire is not exposed out of the catheter and/or the guide wire is not detected to exit. The deep vein puncture guide wire video monitoring system is applied to a deep vein puncture guide wire video monitoring method. The deep vein puncture guide wire video monitoring method is used in electronic equipment.